Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Oncology

Pharmacology/Therapy

Outcome of 490 desensitizations to chemotherapy drugs with a rapid one-solution protocol

The Journal of Allergy and Clinical Immunology: In Practice | Jan 24, 2018 Pharmacology/Therapy

Hyperthermic intraperitoneal chemotherapy in ovarian cancer

New England Journal of Medicine | Jan 23, 2018 Pharmacology/Therapy

Phase II study of BGJ398 in patients with FGFR-altered advanced cholangiocarcinoma

Journal of Clinical Oncology | Jan 23, 2018 Pharmacology/Therapy

Improvement in overall survival with carfilzomib, lenalidomide, and dexamethasone in patients with relapsed or refractory multiple myeloma

Journal of Clinical Oncology | Jan 22, 2018 Pharmacology/Therapy

Randomized phase 2 study of tivantinib plus erlotinib vs single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancer

Lung Cancer | Jan 22, 2018 Pharmacology/Therapy

A phase III randomised study comparing concomitant radiochemotherapy with cisplatin and docetaxel as induction vs consolidation treatment in patients with locally advanced unresectable non-small cell lung cancer

Lung Cancer | Jan 22, 2018 Pharmacology/Therapy

Shortened-duration tacrolimus after nonmyeloablative, HLA-haploidentical BMT

Biology of Blood and Marrow Transplantation | Jan 20, 2018 Pharmacology/Therapy

Sequential vs simultaneous use of chemotherapy and gonadotropin-releasing hormone agonist (GnRHa) among estrogen receptor (ER)-positive premenopausal breast cancer patients: Effects on ovarian function, disease-free survival, and overall survival

Breast Cancer Research and Treatment | Jan 19, 2018 Pharmacology/Therapy

Predictive factors for response to IVIG in children with ITP

Pediatrics International | Jan 19, 2018 Pharmacology/Therapy

Phase II trial of SOM230 (pasireotide LAR) in patients with unresectable hepatocellular carcinoma

Journal of Hepatocellular Carcinoma | Jan 19, 2018 Pharmacology/Therapy

« Prev 1 … 341 342 343 344 345 … 375 Next »

Outcome of 490 desensitizations to chemotherapy drugs with a rapid one-solution protocol

Hyperthermic intraperitoneal chemotherapy in ovarian cancer

Phase II study of BGJ398 in patients with FGFR-altered advanced cholangiocarcinoma

Improvement in overall survival with carfilzomib, lenalidomide, and dexamethasone in patients with relapsed or refractory multiple myeloma

Randomized phase 2 study of tivantinib plus erlotinib vs single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancer

A phase III randomised study comparing concomitant radiochemotherapy with cisplatin and docetaxel as induction vs consolidation treatment in patients with locally advanced unresectable non-small cell lung cancer

Shortened-duration tacrolimus after nonmyeloablative, HLA-haploidentical BMT

Sequential vs simultaneous use of chemotherapy and gonadotropin-releasing hormone agonist (GnRHa) among estrogen receptor (ER)-positive premenopausal breast cancer patients: Effects on ovarian function, disease-free survival, and overall survival

Predictive factors for response to IVIG in children with ITP

Phase II trial of SOM230 (pasireotide LAR) in patients with unresectable hepatocellular carcinoma

MD Clip on Recent Advances in Lipid Management with Dr Gopinath

Article: Anti-Inflammatory Diets for Pain and Arthritis Management

Many young adults have high long-term risk for cardiovascular disease, study finds

Article on Hypertension in CKD Patients: Management Updates

New research aims to transform treatments of aggressive blood cancer

Outcome of 490 desensitizations to chemotherapy drugs with a rapid one-solution protocol

Hyperthermic intraperitoneal chemotherapy in ovarian cancer

Phase II study of BGJ398 in patients with FGFR-altered advanced cholangiocarcinoma

Improvement in overall survival with carfilzomib, lenalidomide, and dexamethasone in patients with relapsed or refractory multiple myeloma

Randomized phase 2 study of tivantinib plus erlotinib vs single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancer

A phase III randomised study comparing concomitant radiochemotherapy with cisplatin and docetaxel as induction vs consolidation treatment in patients with locally advanced unresectable non-small cell lung cancer

Shortened-duration tacrolimus after nonmyeloablative, HLA-haploidentical BMT

Sequential vs simultaneous use of chemotherapy and gonadotropin-releasing hormone agonist (GnRHa) among estrogen receptor (ER)-positive premenopausal breast cancer patients: Effects on ovarian function, disease-free survival, and overall survival

Predictive factors for response to IVIG in children with ITP

Phase II trial of SOM230 (pasireotide LAR) in patients with unresectable hepatocellular carcinoma

MD Clip on Recent Advances in Lipid Management with Dr Gopinath

Article: Anti-Inflammatory Diets for Pain and Arthritis Management

Many young adults have high long-term risk for cardiovascular disease, study finds

Article on Hypertension in CKD Patients: Management Updates

New research aims to transform treatments of aggressive blood cancer

Select Specialty

Select Topic